← back to search

Caroline E Morton

RED Consulting (Norway) · GB
🔎 Find collaborators in Infectious Diseases · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Infectious Diseases · Oncology
Research interest
Research interests include COVID-19 Clinical Research Studies, COVID-19 and healthcare impacts, SARS-CoV-2 and COVID-19 Research, and Long-Term Effects of COVID-19.
h-index
31
citations
12,336
works
143
NIH funding
primary concept
Medicine
email

Recent publications

How Should Meaningful Evidence Be Generated From Datasets?
The AMA Journal of Ethic 2025cited by 1position: firstdoi
Outpatient hospital attendances in people with rheumatoid arthritis during the COVID-19 pandemic and beyond: a cohort study in three nations of the UK
Lara D. Veeken 2025cited by 0position: middledoi
Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)
The Lancet Regional Health - Europe 2024cited by 94position: middledoi
Impact of vaccination on the association of COVID-19 with cardiovascular diseases: An OpenSAFELY cohort study
Nature Communications 2024cited by 37position: middledoi
Genetic basis of early onset and progression of type 2 diabetes in South Asians
Nature Medicine 2024cited by 34position: middledoi
Clinical coding of long COVID in primary care 2020–2023 in a cohort of 19 million adults: an OpenSAFELY analysis
EClinicalMedicine 2024cited by 23position: middledoi
Genetic architecture of routinely acquired blood tests in a British South Asian cohort
Nature Communications 2024cited by 21position: middledoi
Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people
The Lancet Diabetes & Endocrinology 2024cited by 21position: middledoi
Impact of COVID-19 on recorded blood pressure screening and hypertension management in England: an analysis of monthly changes in the quality and outcomes framework indicators in OpenSAFELY
Open Heart 2024cited by 5position: middledoi
Identification of patients undergoing chronic kidney replacement therapy in primary and secondary care data: validation study based on OpenSAFELY and UK Renal Registry
BMJ Medicine 2024cited by 4position: middledoi
Ethnic differences in depression and anxiety among adults with atopic eczema: Population‐based matched cohort studies within UK primary care
Clinical and Translational Allergy 2024cited by 1position: middledoi
Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform
The Lancet Public Health 2023cited by 97position: middledoi
Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY
BMJ Medicine 2023cited by 37position: middledoi
Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational Data
Annals of Internal Medicine 2023cited by 31position: middledoi
Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records
Nature Communications 2022cited by 558position: middledoi
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform
The Lancet Rheumatology 2022cited by 108position: middledoi
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform
BMJ 2022cited by 95position: middledoi
Mortality among Care Home Residents in England during the first and second waves of the COVID-19 pandemic: an observational study of 4.3 million adults over the age of 65
The Lancet Regional Health - Europe 2022cited by 77position: middledoi
Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform
PLoS Medicine 2022cited by 66position: middledoi
Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records
BMJ 2022cited by 62position: middledoi
Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform
Vaccine 2022cited by 30position: middledoi
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY
BMC Medicine 2022cited by 29position: middledoi
Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19 in England: a descriptive cohort study within the OpenSAFELY platform
Wellcome Open Research 2022cited by 22position: middledoi
Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY
BMJ 2022cited by 22position: middledoi
Potentially inappropriate prescribing of DOACs to people with mechanical heart valves: A federated analysis of 57.9 million patients' primary care records in situ using OpenSAFELY
Thrombosis Research 2022cited by 12position: middledoi
Comparison of methods for predicting COVID-19-related death in the general population using the OpenSAFELY platform
Diagnostic and Prognostic Research 2022cited by 8position: middledoi
Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform
The Lancet 2021cited by 562position: middledoi
Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform
The Lancet Regional Health - Europe 2021cited by 208position: middledoi
Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February
Eurosurveillance 2021cited by 202position: middledoi
Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records <i>in situ</i> using OpenSAFELY
British Journal of General Practice 2021cited by 122position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Liam Smeeth · Qatar University6 papers (2020–2023)Krishnan Bhaskaran · Centre de recherche en Epidémiologie et Santé des Populations5 papers (2020–2023)Ben Goldacre · Angkor Hospital for Children5 papers (2020–2024)Christopher T. Rentsch · University of London5 papers (2020–2025)Brian MacKenna · Science Oxford4 papers (2020–2024)Seb Bacon · Science Oxford4 papers (2020–2024)Helen McDonald · University of Tasmania4 papers (2020–2023)Amir Mehrkar · University of Oxford4 papers (2020–2024)Rosalind M. Eggo · London School of Hygiene & Tropical Medicine3 papers (2020–2021)David Evans · United States Census Bureau3 papers (2020–2023)William Hulme · Angkor Hospital for Children3 papers (2020–2023)Helen J Curtis · Angkor Hospital for Children3 papers (2020–2023)Anna Schultze · Brigham and Women's Hospital3 papers (2020–2023)Ian Douglas · London School of Hygiene & Tropical Medicine3 papers (2020–2023)Harriet Forbes · University of Bristol3 papers (2020–2020)Elizabeth Williamson · University of London3 papers (2020–2023)Laurie A. Tomlinson · Science Oxford3 papers (2021–2024)Alex J Walker · Angkor Hospital for Children3 papers (2020–2023)Chris Bates · Texas Public Policy Foundation2 papers (2020–2021)John Parry · London School of Hygiene & Tropical Medicine2 papers (2020–2021)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Infectious Diseases · Oncology →